Yixian Huang

机构：University of Pittsburgh, UPMC Hillman Cancer Center, Universidad Católica Santo Domingo, PharmacoGenetics (China) · ORCID：0009-0004-2601-2875

发表论文 115 篇 · 总被引 3695 次 · h-index 33

代表论文

• miRTarBase 2025: updates to the collection of experimentally validated microRNA–target interactions (2024 · Nucleic Acids Research · 被引 218)
• ACP-CapsPred: an explainable computational framework for identification and functional prediction of anticancer peptides based on capsule network (2024 · Briefings in Bioinformatics · 被引 24)
• Inhibition of heme-thiolate monooxygenase CYP1B1 prevents hepatic stellate cell activation and liver fibrosis by accumulating trehalose (2024 · Science Translational Medicine · 被引 18)
• Depletion of oxysterol-binding proteins by OSW-1 triggers RIP1/RIP3-independent necroptosis and sensitization to cancer immunotherapy (2025 · Cell Death and Differentiation · 被引 14)
• Rational development of gemcitabine-based nanoplatform for targeting SERPINB9/Granzyme B axis to overcome chemo-immune-resistance (2025 · Nature Communications · 被引 10)
• The desulfinylation enzyme sulfiredoxin-1 attenuates HSC activation and liver fibrosis by modulating the PTPN12-NLRP3 axis (2024 · Hepatology · 被引 10)